Intellectual Property

What is Intellectual Property?

Intellectual property (IP) is a property created by the human intellect. Unlike other tangible properties, such as real estate, it is an intangible or non-physical asset. Still, it provides legal rights to the owner, like real estate properties. In the current knowledge-based economy, intellectual property is valuable and expensive to create; thus, it is essential to protect it. Therefore, we assist our clients in protecting their intellectual property from use by others without our client’s consent.
 
We offer the best quality, reliable, prompt, intellectual property-related services at competitive costs to fit your budget needs. To avoid shocking back-end charges, we offer upfront customizable flat, fair fees relative to your innovation’s complexity, translating into the skill, time, and effort required to assemble the application. This model will assist you in planning your patent finances and allocating appropriate resources for your intellectual property. We also offer patent strategies to enhance your patent portfolio while remaining within your resources.
 
We provide below several resources that you may use to educate yourself regarding various intellectual property topics.
  • O’Reilly et al. v. Morse et al., (1853)
  • Graham v. John Deers Co., (1966)
  • Diamond v. Chakrabarty., (1980)
  • Diamond v. Diehr., (1981)
    KSR International Co. v. Teleflex Inc., (2007)
  • Mayo Collaborative Services v. Prometheus Laboratories, Inc., (2012)
  • Association for Molecular Pathology v. Myriad Genetics, Inc., (2013)
  • Alice Corp. v. CLS Bank International., (2014)
  • https://www.supremecourt.gov/opinions/13pdf/13-298_7lh8.pdf
  • Ariosa Diagnostics, INC., Natera, INC., DNA Diagnostics Center, INC., v. Sequenom, INC., Sequenom Center For Molecular Medicine, LLC, ISIS Innovation Limited., (2015)
  • Genetic Technologies Limited, v. Merial L.L.C., Bristol-Myers Squibb Company., (2016)
  • The Cleveland Clinic Foundation, Cleveland HeartLab, INC., v. True Health Diagnostics LLC., (2017)
  • Vanda Pharmaceuticals INC., Aventisub LLC, v. West-Ward Pharmaceuticals International Limited, West-Ward Pharmaceuticals Corp., (2018)
  • Illumina, INC., Sequenom, INC., v. Ariosa Diagnostics, INC., Roche Sequencing Solutions, INC., Roche Molecular Systems, INC., (2020)
  • Boehringer Ingelheim Pharmaceuticals INC. et al. v. Mylan Pharmaceuticals INC. et al., (2020)

Disclaimer: Affordable Patent Agency, LLC provides, in good faith, the materials on this page as a source of information for the readers. The materials may contain incompleteness, incorrect, erroneous, outdated, or inaccurate information. We do not commit and disclaims any duty to update, complete, correct, etc., these resources. The readers must understand that we are not rendering any professional advice for any particular legal problem. The readers should not rely upon these materials as a substitute for independent legal or professional consultation. The material is not a substitute for nor intended as a consultation, legal advice, or opinion.

Scroll to Top